Latest Breaking News On - Office of technology transfer - Page 2 : comparemela.com

The New York Times explained how the government poured $18.5 billion into experimental, fast-tracked vaccines, leaving doctors with “woefully few” drugs to treat the sick. But the author neglected to explain why that happened. On Jan. 30, the New York Times published an article, “How the Search for COVID-19 treatments Faltered While Vaccines Sped Ahead.” The article bemoaned the fact that “nearly a year into the coronavirus pandemic, as thousands of patients are dying every day in the United States and widespread vaccination is still months away, doctors have precious few drugs to fight the virus.” According to the Times: “The government poured $18.5 billion into vaccines, a strategy that resulted in at least five effective products at record-shattering speed. But its investment in drugs was far smaller, about $8.2 billion, most of which went to just a few candidates, such as monoclonal antibodies. Studies of other drugs were poorly organized.

New yorkUnited statesColumbia schoolMerck gardasilRachel maddowAstrazeneca synagisAnthony fauciIan lipkinUs department of healthHuman servicesNational institutes of healthNational institute of allergyCritical care allianceChildren health defenseDrug administrationColumbia school of public health